SYRA OTC
Syra Health Corp. Class A Common Stock
1W: -6.3%
1M: -11.6%
3M: +20.6%
YTD: +845.1%
1Y: +927.8%
$0.82
-0.07 (-7.89%)
Weekly Expected Move ±11.7%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Revenue Segmentation
By Product / Service
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$7M
-9.5% ▼
Gross Profit
$2M
+50.5% ▲
Operating Income
-$904K
+76.0% ▲
Net Income
-$896K
+76.2% ▲
EPS (Diluted)
$-0.08
+85.5% ▲
EBITDA
-$884K
+76.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $1M | $6M | $6M | $8M | $7M |
| YoY Growth | +0.0% | +298.4% | -1.8% | +44.7% | -9.5% |
| Cost of Revenue | $980K | $5M | $4M | $6M | $5M |
| Gross Profit | $430K | $1M | $1M | $2M | $2M |
| Gross Margin | 30.5% | 18.9% | 25.5% | 20.7% | 34.4% |
| R&D Expenses | $0 | $0 | $240K | $585K | $68K |
| SG&A Expenses | $416K | $3M | $4M | $1M | $3M |
| Operating Expenses | $434K | $3M | $4M | $5M | $3M |
| Operating Income | -$3K | -$2M | -$3M | -$4M | -$904K |
| Operating Margin | -0.2% | -37.2% | -52.4% | -47.2% | -12.5% |
| Interest Expense | $0 | $29K | $54K | $16K | $13K |
| Income Before Tax | -$3K | -$2M | -$3M | -$4M | -$896K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$3K | -$2M | -$3M | -$4M | -$896K |
| Net Margin | -0.2% | -37.7% | -53.3% | -47.1% | -12.4% |
| EPS (Diluted) | $-0.00 | $-0.29 | $-0.60 | $-0.52 | $-0.08 |
| EBITDA | -$3K | -$2M | -$3M | -$4M | -$884K |
| Shares Outstanding | 7M | 7M | 5M | 7M | 12M |